P. Muller

发表

Selection of a respiratory syncytial virus fusion inhibitor clinical candidate, part 1: improving the pharmacokinetic profile using the structure-property relationship.

K. Andries, P. Timmerman, E. Arnoult, 2007, Journal of medicinal chemistry.

5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors.

G. Mannens, P. Muller, P. van Remoortere, 2003, Bioorganic & medicinal chemistry letters.

Color Change Effect in an Organic–Inorganic Hybrid Material Based on a Porphyrin Diacid

A. Rahimi‐Iman, M. Schmid, J. M. Gottfried, 2016, 1611.04737.

Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors.

M. Janicot, C. Meyer, G. Mannens, 2003, Bioorganic & medicinal chemistry letters.

Color Change Effect in an Organic–Inorganic Hybrid Material Based on a Porphyrin Diacid

A. Rahimi‐Iman, M. Schmid, J. M. Gottfried, 2016, 1611.04737.

Synthesis Routes Towards the Farnesyl Protein Transferase Inhibitor ZARNESTRATM

P. Muller, P. Angibaud, D. End, 2004 .

A zirconium catalysed synthesis of 1,4-dimagnesium reagents.

P. Muller, R. Whitby, R. Jones, 1991 .

Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121).

K. Andries, C. Meyer, P. Timmerman, 2008, Journal of medicinal chemistry.

Glossary of terms used in physical organic chemistry (IUPAC Recommendations 1994)

P. Muller, 1994 .

A Zirconium Catalyzed Synthesis of 1,4-Dimagnesium Reagents.

P. Muller, R. Whitby, R. Jones, 1992 .